Kim Ross, DCN, MS, MBA, CNS, IFMCP’s Post

Last week was all about SHARING. See my new blog post https://lnkd.in/eW_hixXR “We build a strong foundation” to benefit us all. #patientfirst #precisionpathology #precisionmedicine #digitalpathology

Dive into the latest research from Clario's experts, co-authored by Luc Dekie, Ph.D., Jeff Heilbraun, M.S., Vickas Patel, M.D., Ph.D., and Todd Rudo, M.D. Discover key takeaways highlighting the significance of within-session blood pressure variability (BPV) and its impact on clinical trial conduct. Ready to delve into the nuances of BPV management in clinical trials? Read the full whitepaper here: https://lnkd.in/e-KffKfw #ClinicalTrials #BloodPressureVariability #MedicalResearch

The star of the show isT.J. Sharpe and the reality of why we are still having this exhaustive conversation... is because of courageous humans like you and bewildered humans like me! Thank you so very much for changing my focus when I heard you speak for the first time almost 9 years ago. There is simply no more appropriate perspective than the lived human clinical trial participant and healthcare human experience in demonstrating the WHY NOT!! Informed decision making requires a commitment to ensuring the timely sharing of linked health data generated by patients/study participants wherever they are on their care journey and helps all stakeholders understand the patient experience, the evolution of patient safety, product effectiveness over time and valuable evidence generation. Solutions to ensure a risk-based, meaningful, pro-active, ethical approaches/options for the return of individual participant data and lay summaries demonstrates reciprocity, respect and partnership, requires global harmonization and flexibility and has the ability to transform the cultural thinking about what is possible when we critically think and re-think about our shared mutual objectives, reducing burden on health systems and patients to accelerate medicines development. Essential to ensuring the sustainability of R&D and improving global health equity. Providing pragmatic personalized options which matter most to patients and their care providers and securing mechanisms that will facilitate the convergence of clinical care and clinical research is no longer an option. #DIA2024 Session #373 Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard (MRCT Center) Innovative Health Initiative (IHI) Facilitate Project TransCelerate BioPharma Inc. Society for Clinical Research Sites (SCRS) CISCRP #pfdd #CRACO #Collaborating with #patients to enable a healthier future for all. Enabling #innovation and #equity ambitions through co-creation and global collaboration. #datasharing #patientsaspartners #healthinformation #bioethics

Dive into the latest research from Clario's experts, co-authored by Luc Dekie, Ph.D., Jeff Heilbraun, M.S., Vickas Patel, M.D., Ph.D., and Todd Rudo, M.D. Discover key takeaways highlighting the significance of within-session blood pressure variability (BPV) and its impact on interpreting blood pressure results. Ready to delve into the nuances of managing BPV in your clinical trials? Read the full whitepaper here: https://lnkd.in/e-KffKfw #ClinicalTrials #BloodPressureVariability #MedicalResearch

Healthmetryx is set to play a relevant role in public health. As we respect individual privacy, monitoring population respiratory health conditions is a powerful tool health officials have to implement effective public health strategies.

So honored to be a guest on Unravel Biosciences podcast to speak on the pros and cons of having #CureAP4 focused on identifying therapeutics for a disorder with 4 different pathological gene variants causing the same symptom presentation and the enthusiasm I have for any #TechnologicalInnovation, like Unravel offers, able to catagorize our #RareDisease #Patients into subgroups based on predicted drug response, which can then be used to potentially find commonalities between these subgroups and other subgroups of #HereditarySpasticParaegia and maybe even more mainstream #Disorders.

Hey! Welcome back from your long weekend! The ADA Scientific Sessions conference is on my mind this week and if you work in diabetes and/or obesity, I'm sure it is on your brain too. Our team at Thrivable will be there and I'd love to chat with anyone looking to improve their qualitative, quantitative, human factors and clinical trials. Comment below if you'd like to meet or send me a PM! #ADA2024

Clinical trials are foundational to delivering life-changing treatment to those in need. But diversifying the clinical trial arena is essential to holistic, well-rounded success. To learn more, tune in to this month's episode of Fractals: The Life Sciences Questionnaire with Bracken Senior Partner, Deepak Behera, MD, launching this Thursday, 11/9. #ClinicalTrial #ClinicalDevelopment #LifeSci #FractalsTheLifeSciencesQuestionnaire

So honored to be a guest on Unravel Biosciences podcast to speak on the pros and cons of having #CureAP4 focused on identifying therapeutics for a disorder with 4 different pathological gene variants causing the same symptom presentation and the enthusiasm I have for any #TechnologicalInnovation, like Unravel offers, able to catagorize our #RareDisease #Patients into subgroups based on predicted drug response, which can then be used to potentially find commonalities between these subgroups and other subgroups of #HereditarySpasticParaegia and maybe even more mainstream #Disorders.

A recent study from William Parker, MD, and colleagues at UChicago Medicine, highlights the potential of a continuous allocation score for improving beneficence in donor heart allocation in the US. In this video clip, Michelle Kittleson, MD talks about the advantages of the new scoring system: https://lnkd.in/eaY7EXvC #HeartFailure